Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionSwiss National Bank
Latest Disclosed Ownership168,100 shares
Latest Disclosed Value $ 4,994,251
Swiss National Bank reports 0.60% increase in ownership of TVTX / Travere Therapeutics, Inc.

On May 7, 2026 - Swiss National Bank filed a 13F-HR form disclosing ownership of 168,100 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $4,994,251 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 167,100 shares of Travere Therapeutics, Inc.. This represents a change in shares of 0.60% during the quarter. The current value of the position is $7,598,120 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 168,100 1,000 0.60 4,994 -21.77 0.0029
2026-02-12 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 167,100 3,500 2.14 6,385 63.27 0.0038
2025-11-13 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 163,600 2,500 1.55 3,910 64.01 0.0023
2025-08-12 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 161,100 3,000 1.90 2,384 -15.85 0.0014
2025-05-12 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 158,100 6,200 4.08 2,833 7.07 0.0020
2025-02-10 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 151,900 17,200 12.77 2,646 40.45 0.0018
2024-11-07 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 134,700 0 0.00 1,884 70.19 0.0012
2024-08-08 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 134,700 -12,900 -8.74 1,107 -2.64 0.0008
2024-05-07 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 147,600 0 0.00 1,138 -14.25 0.0008
2024-02-06 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 147,600 0 0.00 1,327 0.53 0.0010
2023-11-08 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 147,600 9,700 7.03 1,320 -37.72 0.0010
2023-08-09 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 137,900 -2,800 -1.99 2,118 -33.06 0.0014
2023-05-10 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 140,700 9,400 7.16 3,164 14.60 0.0022
2023-02-08 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 131,300 3,300 2.58 2,761 -12.46 0.0020
2022-11-09 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 128,000 1,400 1.11 3,154 2.80 0.0023
2022-08-09 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 126,600 -3,700 -2.84 3,068 -8.64 0.0021
2022-05-09 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 130,300 10,100 8.40 3,358 -10.00 0.0019
2022-02-08 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 120,200 0 0.00 3,731 27.99 0.0022
2021-11-08 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 120,200 5,900 5.16 2,915 74.76 0.0019
2021-08-06 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 114,300 -4,200 -3.54 1,668 -43.63 0.0010
2021-05-07 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 118,500 20,700 21.17 2,959 10.99 0.0020
2021-02-05 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 97,800 2,100 2.19 2,666 50.88 0.0019
2020-11-09 2020-09-30 13F RETROPHIN COM 761299106 95,700 1,700 1.81 1,767 -7.92 0.0014
2020-08-05 2020-06-30 13F RETROPHIN COM 761299106 94,000 19,000 25.33 1,919 75.41 0.0016
2020-05-08 2020-03-31 13F RETROPHIN COM 761299106 75,000 1,000 1.35 1,094 4.09 0.0012
2020-02-06 2019-12-31 13F RETROPHIN COM 761299106 74,000 4,600 6.63 1,051 30.72 0.0011
2019-11-12 2019-09-30 13F RETROPHIN COM 761299106 69,400 0 0.00 804 -42.32 0.0009
2019-08-02 2019-06-30 13F RETROPHIN COM 761299106 69,400 1,700 2.51 1,394 -9.01 0.0015
2019-05-10 2019-03-31 13F RETROPHIN COM 761299106 67,700 4,000 6.28 1,532 6.24 0.0017
2019-02-13 2018-12-31 13F RETROPHIN COM 761299106 63,700 0 0.00 1,442 -21.20 0.0018
2018-11-08 2018-09-30 13F RETROPHIN COM 761299106 63,700 0 0.00 1,830 5.41 0.0020
2018-08-09 2018-06-30 13F RETROPHIN COM 761299106 63,700 0 0.00 1,736 21.91 0.0020
2018-05-04 2018-03-31 13F RETROPHIN COM 761299106 63,700 4,000 6.70 1,424 13.20 0.0017
2018-02-07 2017-12-31 13F RETROPHIN COM 761299106 59,700 0 0.00 1,258 -15.34 0.0014
2017-11-03 2017-09-30 13F RETROPHIN COM 761299106 59,700 0 0.00 1,486 28.32 0.0017
2017-08-09 2017-06-30 13F RETROPHIN COM 761299106 59,700 6,300 11.80 1,158 17.44 0.0014
2017-05-04 2017-03-31 13F RETROPHIN COM 761299106 53,400 0 0.00 986 -2.47 0.0012
2017-02-08 2016-12-31 13F RETROPHIN COM 761299106 53,400 0 0.00 1,011 -15.40 0.0016
2016-11-07 2016-09-30 13F RETROPHIN COM 761299106 53,400 -2,800 -4.98 1,195 19.38 0.0019
2016-08-03 2016-06-30 13F RETROPHIN COM 761299106 56,200 6,300 12.63 1,001 52.59 0.0016
2016-05-04 2016-03-31 13F RETROPHIN COM 761299106 49,900 11,700 30.63 656 -10.99 0.0012
2016-02-03 2015-12-31 13F RETROPHIN COM 761299106 38,200 0 0.00 737 -4.78 0.0018
2015-11-04 2015-09-30 13F RETROPHIN COM 761299106 38,200 6,500 20.50 774 -26.36 0.0020
2015-08-05 2015-06-30 13F RETROPHIN COM 761299106 31,700 31,700 1,051 0.0027
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.